Abstract | BACKGROUND AND AIMS: APPROACH AND RESULTS: Here, we show that hepatocyte-specific deletion of TIPE1 exacerbated diet-induced hepatic steatosis, inflammation, and fibrosis as well as systemic metabolic disorders during NASH pathogenesis. Conversely, hepatocyte-specific overexpression of TIPE1 dramatically prevented the progression of these abnormalities. Mechanically, TIPE1 directly interacted with apoptosis signal-regulating kinase 1 (ASK1) to suppress its TNF receptor-associated factor 6 (TRAF6)-catalyzed polyubiquitination activation upon metabolic challenge, thereby inhibiting the downstream c-Jun N-terminal kinase and p38 signaling pathway. Importantly, dramatically reduced TIPE1 expression was observed in the livers of patients with NAFLD, suggesting that TIPE1 might be a promising therapeutic target for NAFLD and related metabolic diseases. CONCLUSIONS: TIPE1 protects against hepatic steatosis, inflammation, and fibrosis through directly binding ASK1 and restraining its TRAF6-catalyzed polyubiquitination during the development of NASH. Therefore, targeting TIPE1 could be a promising therapeutic approach for NAFLD treatment.
|
Authors | Hong Wu, Xiaolei Xu, Ancheng Zheng, Weina Wang, Li Mei, Yue Chen, Shasha Sun, Liujun Jiang, Yutao Wu, Yijiang Zhou, Min Zheng, Qishan Chen |
Journal | Hepatology (Baltimore, Md.)
(Hepatology)
Vol. 74
Issue 3
Pg. 1251-1270
(09 2021)
ISSN: 1527-3350 [Electronic] United States |
PMID | 33713358
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 by the American Association for the Study of Liver Diseases. |
Chemical References |
- Intracellular Signaling Peptides and Proteins
- TIPE1 protein, mouse
- TNFAIP8L1 protein, human
- Polyubiquitin
- MAP Kinase Kinase Kinase 5
|
Topics |
- Adult
- Aged
- Animals
- Diet, High-Fat
- Down-Regulation
- Fatty Liver
(genetics, metabolism, pathology)
- Female
- Humans
- Inflammation
- Intracellular Signaling Peptides and Proteins
(genetics, metabolism)
- Liver Cirrhosis
(genetics, metabolism, pathology)
- MAP Kinase Kinase Kinase 5
(metabolism)
- Male
- Mice, Knockout
- Mice, Transgenic
- Middle Aged
- Non-alcoholic Fatty Liver Disease
(genetics, metabolism)
- Polyubiquitin
(metabolism)
|